Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1994 Feb;71(2):141–145. doi: 10.1136/hrt.71.2.141

Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction.

C Roffe 1, S Fletcher 1, K L Woods 1
PMCID: PMC483633  PMID: 8130021

Abstract

OBJECTIVE--To examine the effect of doubling serum magnesium concentration on the incidence of arrhythmias in patients with suspected acute myocardial infarction. DESIGN--Randomised double blind clinical trial. SETTING--Coronary care unit of a teaching hospital. PATIENTS--Clinical data were collected on 2316 randomised patients with suspected acute myocardial infarction. Holter monitoring was performed in a subgroup of 70 patients and analysed in 48 patients in whom acute myocardial infarction was confirmed. INTERVENTIONS--By random allocation, patients received either an intravenous loading dose of 8 mmol magnesium sulphate over five minutes plus 65 mmol over the next 24 hours, or equal volumes of saline. MAIN OUTCOME MEASURES--(a) Clinically documented arrhythmias; (b) use of antiarrhythmic treatments, cardioversion, and insertion of a pacemaker; (c) incidence of all abnormal rhythms during Holter monitoring. RESULTS--In the main trial the incidence of rhythm disturbance while in the coronary care unit (expressed as the odds ratio (OR) for magnesium: placebo and its 95% confidence interval) was not significantly different between treatment groups for ventricular fibrillation (OR 0.74; 0.46 to 1.20), ventricular tachycardia (OR 0.87; 0.63 to 1.20), supraventricular tachycardia (OR 0.69; 0.38 to 1.26), atrial fibrillation (OR 0.92; 0.69 to 1.23), or heart block of any degree (OR 1.17; 0.83 to 1.65). Sinus bradycardia was significantly more common in the magnesium group (OR 1.38; 1.03 to 1.85; p = 0.02). These findings were corroborated by the use of treatments for rhythm disturbance and the data from Holter monitoring. CONCLUSION--The regimen of intravenous magnesium sulphate used here had no significant effect on arrhythmia in acute myocardial infarction. The reduction in mortality that has been shown with this form of treatment is not attributable to suppression of life threatening rhythm disturbances.

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham A. S., Rosenmann D., Kramer M., Balkin J., Zion M. M., Farbstien H., Eylath U. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med. 1987 Apr;147(4):753–755. [PubMed] [Google Scholar]
  2. Allen B. J., Brodsky M. A., Capparelli E. V., Luckett C. R., Iseri L. T. Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia. Am J Cardiol. 1989 Nov 15;64(18):1202–1204. doi: 10.1016/0002-9149(89)90880-1. [DOI] [PubMed] [Google Scholar]
  3. Barros L. F., Da-Luz P. L., Silveira M. C., Chagas A. C., Pileggi F. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate. Braz J Med Biol Res. 1988;21(4):791–799. [PubMed] [Google Scholar]
  4. Billman G. E., Hoskins R. S. Prevention of ventricular fibrillation with magnesium sulfate. Eur J Pharmacol. 1988 Dec 6;158(1-2):167–171. doi: 10.1016/0014-2999(88)90269-5. [DOI] [PubMed] [Google Scholar]
  5. Bril A., Rochette L. Prevention of reperfusion-induced ventricular arrhythmias in isolated rat heart with magnesium. Can J Physiol Pharmacol. 1990 Jun;68(6):694–699. doi: 10.1139/y90-105. [DOI] [PubMed] [Google Scholar]
  6. Ceremuzyński L., Jurgiel R., Kulakowski P., Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. Am Heart J. 1989 Dec;118(6):1333–1334. doi: 10.1016/0002-8703(89)90027-6. [DOI] [PubMed] [Google Scholar]
  7. Davidenko J. M., Cohen L., Goodrow R., Antzelevitch C. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium. Circulation. 1989 Mar;79(3):674–686. doi: 10.1161/01.cir.79.3.674. [DOI] [PubMed] [Google Scholar]
  8. DiCarlo L. A., Jr, Morady F., de Buitleir M., Krol R. B., Schurig L., Annesley T. M. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol. 1986 Jun;7(6):1356–1362. doi: 10.1016/s0735-1097(86)80157-7. [DOI] [PubMed] [Google Scholar]
  9. England M. R., Gordon G., Salem M., Chernow B. Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. JAMA. 1992 Nov 4;268(17):2395–2402. [PubMed] [Google Scholar]
  10. Etienne Y., Blanc J. J., Boschat J., Le Potier J., Jobic Y., Le Grand O., Penther P. Effets antiarythmiques du sulfate de magnésium intraveineux dans les tachycardies supraventriculaires paroxystiques. Ann Cardiol Angeiol (Paris) 1988 Nov;37(9):535–538. [PubMed] [Google Scholar]
  11. Feldstedt M., Boesgaard S., Bouchelouche P., Svenningsen A., Brooks L., Lech Y., Aldershvile J., Skagen K., Godtfredsen J. Magnesium substitution in acute ischaemic heart syndromes. Eur Heart J. 1991 Nov;12(11):1215–1218. doi: 10.1093/eurheartj/12.11.1215. [DOI] [PubMed] [Google Scholar]
  12. Hasegawa J., Matsumoto T., Takami T., Fujimoto Y., Kotake H., Mashiba H. Suppression of catecholamine-induced abnormal pacemaker activities by magnesium ion in guinea pig cardiac muscle cells. Magnesium. 1989;8(2):94–99. [PubMed] [Google Scholar]
  13. Iseri L. T., Fairshter R. D., Hardemann J. L., Brodsky M. A. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J. 1985 Oct;110(4):789–794. doi: 10.1016/0002-8703(85)90458-2. [DOI] [PubMed] [Google Scholar]
  14. Kulick D. L., Hong R., Ryzen E., Rude R. K., Rubin J. N., Elkayam U., Rahimtoola S. H., Bhandari A. K. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease. Am Heart J. 1988 Feb;115(2):367–373. doi: 10.1016/0002-8703(88)90483-8. [DOI] [PubMed] [Google Scholar]
  15. Morton B. C., Nair R. C., Smith F. M., McKibbon T. G., Poznanski W. J. Magnesium therapy in acute myocardial infarction--a double-blind study. Magnesium. 1984;3(4-6):346–352. [PubMed] [Google Scholar]
  16. Perticone F., Ceravolo R., Costa R., Mattioli P. L. Electrophysiologic effects of magnesium sulfate infusion in patients with cardiac conduction defects. J Am Coll Nutr. 1992 Aug;11(4):405–409. doi: 10.1080/07315724.1992.10718244. [DOI] [PubMed] [Google Scholar]
  17. Rasmussen H. S., Suenson M., McNair P., Nørregård P., Balslev S. Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study. Clin Cardiol. 1987 Jun;10(6):351–356. doi: 10.1002/clc.4960100610. [DOI] [PubMed] [Google Scholar]
  18. Rasmussen H. S., Thomsen P. E. The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle. Clin Cardiol. 1989 Feb;12(2):85–90. doi: 10.1002/clc.4960120204. [DOI] [PubMed] [Google Scholar]
  19. Rogiers P., Vermeier W., Kesteloot H., Stroobandt R. Effect of the infusion of magnesium sulfate during atrial pacing on ECG intervals, serum electrolytes, and blood pressure. Am Heart J. 1989 Jun;117(6):1278–1283. doi: 10.1016/0002-8703(89)90406-7. [DOI] [PubMed] [Google Scholar]
  20. Shechter M., Hod H., Marks N., Behar S., Kaplinsky E., Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol. 1990 Aug 1;66(3):271–274. doi: 10.1016/0002-9149(90)90834-n. [DOI] [PubMed] [Google Scholar]
  21. Smith L. F., Heagerty A. M., Bing R. F., Barnett D. B. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol. 1986 Aug;12(2):175–183. doi: 10.1016/0167-5273(86)90239-1. [DOI] [PubMed] [Google Scholar]
  22. Tzivoni D., Banai S., Schuger C., Benhorin J., Keren A., Gottlieb S., Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation. 1988 Feb;77(2):392–397. doi: 10.1161/01.cir.77.2.392. [DOI] [PubMed] [Google Scholar]
  23. Wesley R. C., Jr, Haines D. E., Lerman B. B., DiMarco J. P., Crampton R. S. Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol. 1989 May 1;63(15):1129–1131. doi: 10.1016/0002-9149(89)90092-1. [DOI] [PubMed] [Google Scholar]
  24. White R. E., Hartzell H. C. Magnesium ions in cardiac function. Regulator of ion channels and second messengers. Biochem Pharmacol. 1989 Mar 15;38(6):859–867. doi: 10.1016/0006-2952(89)90272-4. [DOI] [PubMed] [Google Scholar]
  25. Woods K. L., Fletcher S., Roffe C., Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet. 1992 Jun 27;339(8809):1553–1558. doi: 10.1016/0140-6736(92)91828-v. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES